A Frailty Index Based on Deficit Accumulation Quantifies Mortality Risk in Humans and in Mice

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Rockwood, K ^a   Blodgett, J M ^a   Theou, O ^a   Sun, M H ^a   Feridooni, H A ^a   Mitnitski, A ^a   Rose, R A ^a   Godin, J ^a   Gregson, E ^a   Howlett, S E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANIMAL; FEMALE; FRAILTY; HUMAN; MALE; MIDDLE AGED; MORTALITY; MOUSE; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ANIMALS; FEMALE; FRAILTY; HUMANS; MALE; MICE; MIDDLE AGED; YOUNG ADULT;

EID: 85013408967     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43068     Document Type: Article

References (42)

1. Vaupel, J. W. et al. Biodemographic trajectories of longevity. Science 280, 855-860 (1998).
2. Vaupel, J. W., Mantron, K. G. & Stallard, E. The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 16, 439-454 (1979).
3. Clegg, A., Young, J., Iliffe, S., Rikkert, M. O. & Rockwood, K. Frailty in elderly people. Lancet 381, 752-762 (2013).
4. Saunderson et al. Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges. Age Ageing 43, 450-455 (2014).
5. Kennedy et al. Geroscience: linking aging to chronic disease. Cell 159, 709-713 (2014).
6. Fontana, L., Kennedy, B. K., Longo, V. D., Seals, D. & Melov, S. Medical research: treat ageing. Nature 511, 405-407 (2014).
7. Song, X., Mitnitski, A. & Rockwood, K. Age-related deficit accumulation and the risk of late-life dementia. Alzheimers Res Ther. 6, 54 (2014).
8. Kennedy et al. A Frailty Index predicts 10-year fracture risk in adults age 25 years and older: results from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 25, 2825-2832 (2014).
9. Wallace et al. Accumulation of non-traditional risk factors for coronary heart disease is associated with incident coronary heart disease hospitalization and death. PLoS One 9, e90475 (2014).
10. Howlett, S. E. & Rockwood, K. Ageing: Develop models of frailty. Nature 512, 253 (2014).
11. Mitnitski, A., Mogilner, A. J. & Rockwood, K. Accumulation of deficits as a proxy measure of aging. Scientific World Journal 1, 323-336 (2001).
12. Rockwood, K. & Mitnitski, A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 62, 722-727 (2007).
13. Rockwood, K., Song, X. & Mitnitski, A. Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey. CMAJ 183, E487-494 (2011).
14. Mitnitski, A. & Rockwood, K. The rate of aging: the rate of deficit accumulation does not change over the adult life span. Biogerontology 17, 199-204 (2016).
15. Rockwood, K. & Mitnitski, A. Limits to deficit accumulation in elderly people. Mech Ageing Dev. 127, 494-496 (2006).
16. Armstrong, J. J., Mitnitski, A., Launer, J. L., White, L. R. & Rockwood, K. Frailty in the Honolulu-Asia Aging Study: deficit accumulation in a male cohort followed to 90% mortality. J Gerontol A Biol Sci Med Sci. 70, 125-131 (2015).
17. Pincus, Z. Ageing: A stretch in time. Nature 530, 37-38 (2016).
18. Parks et al. A procedure for creating a frailty index based on deficit accumulation in aging mice. J Gerontol A Biol Sci Med Sci. 67, 217-227 (2012).
19. Kane et al. Impact of Longevity Interventions on a Validated Mouse Clinical Frailty Index. J Gerontol A Biol Sci Med Sci. 71, 333-339 (2016).
20. Taneja, S., Mitnitski, A. B., Rockwood, K. & Rutenberg, A. D. Dynamical network model for age-related health deficits and mortality. Phys Rev E. 93, 022309 (2016).
21. Yashin et al. The quadratic hazard model for analyzing longitudinal data on aging, health, and the life span. Phys Life Rev. 9, 177-188; discussion 195-197 (2012).
22. Huffman et al. Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience. J Gerontol A Biol Sci Med Sci. [Epub ahead of print] (2016).
23. Miller et al. Dysnatremia in Relation to Frailty and Age in Community-dwelling Adults in the National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. [Epub ahead of print] (2016).
24. Moghtadaei et al. The impacts of age and frailty on heart rate and sinoatrial node function. J Physiol. [Epub ahead of print] (2016).
25. Newman et al. Strategies and Challenges in Clinical Trials Targeting Human Aging. J Gerontol A Biol Sci Med Sci. [Epub ahead of print] (2016).
26. Moskalev et al. Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic. Aging Cell 15, 407-415 (2016).
27. Von Zglinicki et al. Frailty in mouse ageing: A conceptual approach. Mech Ageing Dev. [Epub ahead of print] (2016).
28. Burd et al. Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms. J Gerontol A Biol Sci Med Sci. [Epub ahead of print] (2016).
29. Mitnitski, A. & Rockwood, K. Aging as a process of deficit accumulation: its utility and origin. Interdiscip Top Gerontol. 40, 85-98 (2015).
30. Strehler, B. L. & Mildvan, A. S. General theory of mortality and aging. Science 132, 14-21 (1960).
31. Kane, D. A., Warga, R. M. & Kimmel, C. B. Mitotic domains in the early embryo of the zebrafish. Nature 360, 735-737 (1992).
32. Maric-Bilkan et al. Report of the National Heart, Lung, and Blood Institute Working Group on Sex Differences Research in Cardiovascular Disease: Scientific Questions and Challenges. Hypertension 67, 802-807 (2016).
33. Howlett, S. E., Rockwood, M. R., Mitnitski, A. & Rockwood, K. Standard laboratory tests to identify older adults at increased risk of death. BMC Med. 12, 171 (2014).
34. Blodgett, J. M., Theou, O., Howlett, S. E., Wu, F. C. & Rockwood, K. A frailty index based on laboratory deficits in communitydwelling men predicted their risk of adverse health outcomes. Age Ageing 45, 463-468 (2016).
35. Golpanian et al. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Oncotarget 7, 11899-11912 (2016).
36. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. 2014; Available at: http://www.cdc.gov/nchs/nhanes.htm. Accessed January 9 (2017).
37. https://www.cdc.gov/nchs/nhanes/irba98.htm. Accessed January 13 (2017).
38. National Death Index. (http://www.cdc.gov/nchs/ndi/index.htm) Accessed January 9 (2017).
39. Searle, S. D., Mitnitski, A., Gahbauer, E. A., Gill, T. M. & Rockwood, K. A standard procedure for creating a frailty index. BMC Geriatr. 8, 24 (2008).
40. Blodgett, J., Theou, O., Kirkland, S., Andreou, P. & Rockwood, K. Frailty in NHANES: Comparing the frailty index and phenotype. Arch Gerontol Geriatr. 60, 464-470 (2015).
41. Whitehead et al. A clinical frailty index in aging mice: comparisons with frailty index data in humans. J Gerontol A Biol Sci Med Sci. 69, 621-632 (2014).
42. Feridooni, H. A., Sun, M. H., Rockwood, K. & Howlett, S. E. Reliability of a Frailty Index Based on the Clinical Assessment of Health Deficits in Male C57BL/6J Mice. J Gerontol A Biol Sci Med Sci. 70, 686-693 (2015).